Article Per Year (5 Year)
p-Index From 2020 - 2025
0
P-Index
This Author published in this journals
All Journal Jurnal Berkala Epidemiologi
Arini Rahmawati
Universitas Airlangga
Immunology & microbiology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Dominant Factor of Diabetic Neuropathy on Diabetes Mellitus Type 2 Patients Arini Rahmawati; Arief Hargono
Jurnal Berkala Epidemiologi Vol. 6 No. 1 (2018): Jurnal Berkala Epidemiologi
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (407.15 KB) | DOI: 10.20473/jbe.V6I12018.60-68

Abstract

Background: The prevalence of diabetes mellitus (DM) type 2 increased in 2013 by 2.10% from the previous years. It has been reported that the patients of diabetes type 2 patients in RSUD Dr. M. Soewandhi as a public hospital in Surabaya increased in 2014-2016.  Purpose: This study aimed to analyze the dominant factor of diabetic neuropathy in patients with DM type 2. Methods: The study design was case control by taking sample through systematic random sampling. There were 36 respondents contributed in this study as case group and 36 respondents as control group. The independent variables in this study were family history, regulated treatment, diet, physical activity, duration of DM type 2, and hypertension history. Meanwhile, the dependent variable was the diabetic neuropathy of DM type 2 patients. Data were analyzed through a chi square test in order to analyze the relation between variables and logistic regression for dominant variables. Results: Diabetic neuropathy was determined by the regulated treatment (p = 0.02 OR = 5,50), diet (p = 0,04; OR = 4,80), physical activity (p = 0,04; OR = 3,57), and hypertension history (p = 0.03; OR = 3.14). The most dominant factor was regulated treatment (p = 0,01; OR = 13,24). Conclusion: The determinant factors of diabetic neuropathy were regulated treatment, diet, physical activity, and hypertension history, while the most dominant factor was regulated treatment. 
Co-Authors Arief Hargono